Cargando…

Molecular characterisation of cell line models for triple-negative breast cancers

BACKGROUND: Triple-negative breast cancers (BC) represent a heterogeneous subtype of BCs, generally associated with an aggressive clinical course and where targeted therapies are currently limited. Target validation studies for all BC subtypes have largely employed established BC cell lines, which h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grigoriadis, Anita, Mackay, Alan, Noel, Elodie, Wu, Pei Jun, Natrajan, Rachel, Frankum, Jessica, Reis-Filho, Jorge S, Tutt, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546428/ https://www.ncbi.nlm.nih.gov/pubmed/23151021 http://dx.doi.org/10.1186/1471-2164-13-619

Ejemplares similares

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
por: Turner, Nicholas, et al.
Publicado: (2010)

Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement
por: Mackay, Alan, et al.
Publicado: (2011)

Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
por: Bajrami, Ilirjana, et al.
Publicado: (2012)

Are triple-negative tumours and basal-like breast cancer synonymous?
por: Rakha, Emad A, et al.
Publicado: (2007)

Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance
por: Kenicer, Juliet, et al.
Publicado: (2014)

Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control
por: de Rinaldis, Emanuele, et al.
Publicado: (2013)

Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
por: Soady, Kelly J, et al.
Publicado: (2015)

Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer
por: Patel, Nirmesh, et al.
Publicado: (2018)

Controversial issues in the neoadjuvant treatment of triple-negative breast cancer
por: Fitzpatrick, Amanda, et al.
Publicado: (2019)

Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development
por: Bax, Dorine A., et al.
Publicado: (2009)

Comparative Membranome Expression Analysis in Primary Tumors and Derived Cell Lines
por: Uva, Paolo, et al.
Publicado: (2010)

Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing
por: Angona, A, et al.
Publicado: (2016)

Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
por: Iorns, Elizabeth, et al.
Publicado: (2009)

Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants
por: Pareja, Fresia, et al.
Publicado: (2016)

Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance
por: Tarantino, Dalia, et al.
Publicado: (2022)

Rare subtypes of triple negative breast cancer: Current understanding and future directions
por: Thomas, Alexandra, et al.
Publicado: (2023)

Prognostic signatures in breast cancer: correlation does not imply causation
por: Ng, Charlotte, et al.
Publicado: (2012)

In vitro antineoplastic activity in triple-negative breast cancer cell line and in vivo
por: Madeira, Klesia, et al.
Publicado: (2014)

Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial
por: Sipos, O., et al.
Publicado: (2021)

Molecular characterisation of Mycobacterium avium subsp. paratuberculosis in Australia
por: Hodgeman, Rachel, et al.
Publicado: (2021)

Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib
por: Daemen, Anneleen, et al.
Publicado: (2012)

Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers
por: Watkins, Johnathan A, et al.
Publicado: (2014)

Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer
por: Rojas L, Katerin, et al.
Publicado: (2019)

MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines
por: Skok, Kristijan, et al.
Publicado: (2021)

Molecular classification of triple-negative tumors
por: Prat, A, et al.
Publicado: (2011)

Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)
por: Tovey, Holly, et al.
Publicado: (2023)

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases
por: Laimito, Katerin Rojas, et al.
Publicado: (2016)

Proteomic characterisation of triple negative breast cancer cells following CDK4/6 inhibition
por: Beykou, Melina, et al.
Publicado: (2022)

DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference
por: Jiao, Yan, et al.
Publicado: (2011)

Characterising protein/detergent complexes by triple-detection size-exclusion chromatography
por: Gimpl, Katharina, et al.
Publicado: (2016)

Molecular Classification of Triple-Negative Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2016)

Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends
por: Pinilla, Karen, et al.
Publicado: (2022)

Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer
por: Johnstone, Cameron N., et al.
Publicado: (2018)

An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk
por: Yau, Christina, et al.
Publicado: (2013)

Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication
por: Liu, Fangfang, et al.
Publicado: (2021)

Establishment and characterisation of an Epstein-Barr virus negative B immunoblastic lymphoma cell line.
por: Ho, Y. S., et al.
Publicado: (1990)

Molecular characteristics of recurrent triple-negative breast cancer
por: TSAI, CHUNG-HSIN, et al.
Publicado: (2015)

Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines
por: Campbell, James, et al.
Publicado: (2016)

Genetic Alterations of Triple Negative Breast Cancer By Targeted Next Generation Sequencing And Correlation With Tumor Morphology
por: Weisman, Paul S, et al.
Publicado: (2016)

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lpvgbcu5tfov8l8n0nnbo0v6em